Education: Doctorate
The Department of Cell and Tissue Genomics is seeking a creative, rigorous, and motivated Scientist 3 to execute cutting-edge single-cell and functional genomic techniques to study cancer biology. The successful candidate will perform high-throughput screens, deploy new and existing single cell profiling methods, and analyze genomic data to enable the interrogation of molecular mechanisms underlying disease states and identify candidate targets for therapeutic interventions.
Working in collaboration with colleagues in the departments of Research Oncology, Translational Medicine, and/or Computational Sciences, this is a hands-on position with both experimental and computational analysis components.
The expected salary range for this position based on the primary location of California is $103,400 - $192,000. Actual pay will be determined based on experience, qualifications, geographic location, and other job-related factors permitted by law. A discretionary annual bonus may be available based on individual and Company performance.
This position also qualifies for the benefits detailed at the link provided below.
Genentech is an equal opportunity employer. It is our policy and practice to employ, promote, and otherwise treat any and all employees and applicants on the basis of merit, qualifications, and competence. The company's policy prohibits unlawful discrimination, including but not limited to, discrimination on the basis of Protected Veteran status, individuals with disabilities status, and consistent with all federal, state, or local laws.
If you have a disability and need an accommodation in relation to the online application process, please contact us by completing this form Accommodations for Applicants .
Search Scientist 3, Single Cell & Functional Genomics jobs near South San Francisco → Browse all live jobs
This posting was published by Roche on their own careers system and is shown here with a direct link to apply there. Employers: for corrections or removal, contact jobs@veritahire.com.